当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析 - 现金流量表

易明医药

(002826)

  

流通市值:26.92亿  总市值:27.88亿
流通股本:1.84亿   总股本:1.91亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金627,745,936.12414,886,173.52213,713,764.53740,991,846.73
  收到的税费返还---1,745.95
  收到其他与经营活动有关的现金31,729,680.6529,644,250.211,155,820.9840,786,496.04
  经营活动现金流入小计659,475,616.77444,530,423.73214,869,585.51781,780,088.72
  购买商品、接受劳务支付的现金103,886,134.4861,326,576.924,632,881.78119,463,271.45
  支付给职工以及为职工支付的现金85,350,100.6763,984,414.0928,054,288.3183,370,767.38
  支付的各项税费79,184,002.7953,443,923.6224,602,245.5198,064,359.87
  支付其他与经营活动有关的现金153,605,253.1491,819,567.5358,210,388.91357,161,524.23
  经营活动现金流出小计422,025,491.08270,574,482.14135,499,804.51658,059,922.93
  经营活动产生的现金流量净额237,450,125.69173,955,941.5979,369,781123,720,165.79
二、投资活动产生的现金流量:
  收回投资收到的现金1,280,000,000880,000,000200,000,000714,000,000
  取得投资收益收到的现金2,874,723.51,775,874.79215,833.343,503,648.94
  处置固定资产、无形资产和其他长期资产收回的现金净额186,770186,000186,000150,218.06
  收到的其他与投资活动有关的现金---3,005,174.13
  投资活动现金流入小计1,283,061,493.5881,961,874.79200,401,833.34720,659,041.13
  购建固定资产、无形资产和其他长期资产支付的现金3,953,708.371,459,740.24818,138.918,495,636.16
  投资支付的现金1,610,000,0001,110,000,000400,000,000714,000,000
  投资活动现金流出小计1,613,953,708.371,111,459,740.24400,818,138.91722,495,636.16
  投资活动产生的现金流量净额-330,892,214.87-229,497,865.45-200,416,305.57-1,836,595.03
三、筹资活动产生的现金流量:
  取得借款收到的现金55,390,00028,800,000-22,108,171.39
  收到其他与筹资活动有关的现金34,820,933.9528,644,00028,644,00024,510,000
  筹资活动现金流入小计90,210,933.9557,444,00028,644,00046,618,171.39
  偿还债务支付的现金11,249,841.6911,249,841.6911,249,841.6933,657,536.66
  分配股利、利润或偿付利息支付的现金28,840,468.0428,522,362.2136,811.9823,843,512.16
  支付其他与筹资活动有关的现金69,998,575.56---
  筹资活动现金流出小计110,088,885.2939,772,203.911,286,653.6757,501,048.82
  筹资活动产生的现金流量净额-19,877,951.3417,671,796.117,357,346.33-10,882,877.43
四、汇率变动对现金及现金等价物的影响-467,212.07-457,296.9-418,483.11-734,015.58
五、现金及现金等价物净增加额-113,787,252.59-38,327,424.66-104,107,661.35110,266,677.75
  加:期初现金及现金等价物余额537,664,815.13537,664,815.13537,664,815.13427,398,137.38
  期末现金及现金等价物余额423,877,562.54499,337,390.47433,557,153.78537,664,815.13
补充资料:
  净利润-66,679,694.56-93,124,133.45
  资产减值准备-435,423.75-1,531,500.61
  固定资产和投资性房地产折旧-8,120,128.76-17,413,624.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-8,120,128.76-17,413,624.13
  无形资产摊销-384,138.65-1,722,713.28
  处置固定资产、无形资产和其他长期资产的损失-87,487.98-231,318.41
  固定资产报废损失-21,079.09-29,891.21
  财务费用-116,866.29-120,423.33
  投资损失--1,739,655.7--3,496,674.69
  递延所得税-132,428.83--1,834,834.4
  其中:递延所得税资产减少-132,428.83--1,834,834.4
  存货的减少-5,766,107.69--18,735,945.11
  经营性应收项目的减少-69,529,176.39-26,549,692.58
  经营性应付项目的增加-24,423,065.3-8,842,106.33
  其他----1,777,783.34
  现金的期末余额-499,337,390.47-537,664,815.13
  减:现金的期初余额-537,664,815.13-427,398,137.38
  现金及现金等价物的净增加额--38,327,424.66-110,266,677.75
公告日期2026-10-282026-08-272026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑